Skip to search formSkip to main contentSkip to account menu

GSK 1070916

Known as: GSK-1070916, GSK1070916 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Aza CompoundsIndoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
349 Synergistic drug combinations that target beta-catenin-driven and MYC-driven cancers
2010
2010
3D-QSAR and Molecular Docking Studies on Derivatives of MK-0457, GSK1070916 and SNS-314 as Inhibitors against
Abstract: Development of anticancer drugs targeting Aurora B, an important member of the serine/threonine kinases family, has… 
2009
2009
Biochemical characterization of GSK 1070916 , a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time 1
Kelly ANDERSON*, Zhihong LAI*, Octerloney B. MCDONALD†, J. Darren STUART‡, Eldridge N. NARTEY‡, Mary Ann HARDWICKE§, Ken… 
2008
2008
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B kinase with an extremely slow off-rate.
5649 Aurora kinases (Aurora A, B and C) are serine/threonine protein kinases that play essential roles in mitosis and cytokinesis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)